How many stocks are there of Nkarta?
The current number of stocks of Nkarta is 49.01 M undefined.
Nkarta Stocks 2025
Nkarta Stocks
49.01 M
Ticker
NKTX
ISIN
US65487U1088
WKN
A2P797
In 2025, Nkarta had 49.01 M outstanding stocks, a 0% change from the 49.01 M stocks in the previous year.
The Nkarta Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2030e | 49.01 |
| 2029e | 49.01 |
| 2028e | 49.01 |
| 2027e | 49.01 |
| 2026e | 49.01 |
| 2025e | 49.01 |
| 2024e | 49.01 |
| 2023 | 49.01 |
| 2022 | 43.63 |
| 2021 | 32.86 |
| 2020 | 32.63 |
| 2019 | 30.43 |
| 2018 | 30.43 |
Nkarta shares outstanding US65487U1088 · A2P797
The number of shares was Nkarta in 2024 — This indicates how many shares 49.014 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Nkarta earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Nkarta's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Nkarta’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Nkarta's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2018 | 30.43 M Aktien |
| 2019 | 30.43 M Aktien |
| 2020 | 32.63 M Aktien |
| 2021 | 32.86 M Aktien |
| 2022 | 43.63 M Aktien |
| 2023 | 49.01 M Aktien |
| 2024e | 49.01 M Aktien |
| 2025e | 49.01 M Aktien |
| 2026e | 49.01 M Aktien |
| 2027e | 49.01 M Aktien |
| 2028e | 49.01 M Aktien |
| 2029e | 49.01 M Aktien |
| 2030e | 49.01 M Aktien |
Nkarta Aktienanalyse
What does Nkarta do?
Nkarta Inc is a biopharmaceutical company based in South San Francisco, California. The company was founded in 2015 by Dr. Raphael Rousseau (CEO) to develop a groundbreaking new therapy for cancer patients. The business model of Nkarta is based on the development of novel CAR-T cell therapies. These are a special type of immunotherapy in which the patient's own immune cells are genetically modified and used to target tumor cells. Unlike conventional chemotherapy or radiation, which can also attack healthy cells, CAR-T cell therapies specifically target cancer cells while sparing the surrounding healthy tissue. Nkarta is divided into various business areas, including research and development of new therapies, manufacturing and production of CAR-T cells, and clinical trials and approval processes for broad application. One of Nkarta's key products is NKR-2, a CAR-T cell therapy based on natural killer cells. These cells have high activity against cancer cells and can respond quickly to threats. NKR-2 differentiates itself from other therapies by its ability to be effective even at low concentrations. This means that fewer cells are needed and the risk of unwanted side effects is reduced. Nkarta is also working on other projects, including NKX101, which specializes in treating solid tumors, and Voretigene Neparvovec, a gene therapy for the rare hereditary retinal disease. In 2020, Nkarta entered into a partnership with CRISPR Therapeutics to explore the joint potential of CRISPR gene editing and CAR-T cell therapy. The collaboration aims to improve the precision and effectiveness of CAR-T cell therapies and ultimately increase the chances of a cure for cancer patients. Overall, Nkarta has had an impressive success story in recent years. The company has raised several million dollars in funding and continues to expand. The groundbreaking technology of CAR-T cell therapies is promising and has the potential to have a sustainable impact on healthcare. With Nkarta at the forefront, the future could look much more hopeful for cancer patients. Nkarta ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Nkarta's Shares Outstanding
Nkarta's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Nkarta’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Nkarta’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Nkarta’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Nkarta stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Nkarta are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Nkarta evolved in recent years?
The number of shares of Nkarta has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Nkarta as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Nkarta?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Nkarta pay?
Over the past 12 months, Nkarta paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nkarta is expected to pay a dividend of 0 USD.
What is the dividend yield of Nkarta?
The current dividend yield of Nkarta is .
When does Nkarta pay dividends?
Nkarta pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Nkarta?
Nkarta paid dividends every year for the past 0 years.
What is the dividend of Nkarta?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Nkarta located?
Nkarta is assigned to the 'Health' sector.
Wann musste ich die Aktien von Nkarta kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Nkarta from 2/5/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 2/5/2025.
When did Nkarta pay the last dividend?
The last dividend was paid out on 2/5/2025.
What was the dividend of Nkarta in the year 2024?
In the year 2024, Nkarta distributed 0 USD as dividends.
In which currency does Nkarta pay out the dividend?
The dividends of Nkarta are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Nkarta
Our stock analysis for Nkarta Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nkarta Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
